nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—Intraocular pressure increased—Hydrochlorothiazide—nephrolithiasis	0.0436	0.0599	CcSEcCtD
Triamcinolone—PTGS2—nephron—nephrolithiasis	0.0412	0.151	CbGeAlD
Triamcinolone—Trauma—Hydrochlorothiazide—nephrolithiasis	0.0403	0.0554	CcSEcCtD
Triamcinolone—NR3C1—urine—nephrolithiasis	0.0382	0.14	CbGeAlD
Triamcinolone—CYP3A4—urine—nephrolithiasis	0.0289	0.106	CbGeAlD
Triamcinolone—Peptic ulcer—Hydrochlorothiazide—nephrolithiasis	0.0287	0.0394	CcSEcCtD
Triamcinolone—Stinging—Hydrochlorothiazide—nephrolithiasis	0.0237	0.0325	CcSEcCtD
Triamcinolone—Glycosuria—Hydrochlorothiazide—nephrolithiasis	0.0237	0.0325	CcSEcCtD
Triamcinolone—SERPINA6—nephron tubule—nephrolithiasis	0.0235	0.0861	CbGeAlD
Triamcinolone—SERPINA6—renal system—nephrolithiasis	0.0213	0.0783	CbGeAlD
Triamcinolone—SERPINA6—kidney—nephrolithiasis	0.0206	0.0757	CbGeAlD
Triamcinolone—SERPINA6—cortex of kidney—nephrolithiasis	0.0201	0.0737	CbGeAlD
Triamcinolone—Vasculitis—Hydrochlorothiazide—nephrolithiasis	0.0196	0.027	CcSEcCtD
Triamcinolone—Wheezing—Hydrochlorothiazide—nephrolithiasis	0.0186	0.0256	CcSEcCtD
Triamcinolone—Ecchymosis—Hydrochlorothiazide—nephrolithiasis	0.0173	0.0238	CcSEcCtD
Triamcinolone—Pulmonary oedema—Hydrochlorothiazide—nephrolithiasis	0.0171	0.0235	CcSEcCtD
Triamcinolone—Diabetes mellitus—Hydrochlorothiazide—nephrolithiasis	0.016	0.022	CcSEcCtD
Triamcinolone—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.0156	0.0214	CcSEcCtD
Triamcinolone—Injury—Hydrochlorothiazide—nephrolithiasis	0.0151	0.0208	CcSEcCtD
Triamcinolone—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.0148	0.0204	CcSEcCtD
Triamcinolone—Purpura—Hydrochlorothiazide—nephrolithiasis	0.0144	0.0199	CcSEcCtD
Triamcinolone—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.0137	0.0188	CcSEcCtD
Triamcinolone—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.0132	0.0181	CcSEcCtD
Triamcinolone—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.0123	0.0169	CcSEcCtD
Triamcinolone—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.0121	0.0167	CcSEcCtD
Triamcinolone—Influenza—Hydrochlorothiazide—nephrolithiasis	0.012	0.0165	CcSEcCtD
Triamcinolone—Pancreatitis—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0162	CcSEcCtD
Triamcinolone—BCHE—nephron tubule—nephrolithiasis	0.0115	0.0424	CbGeAlD
Triamcinolone—Upper respiratory tract infection—Hydrochlorothiazide—nephrolithiasis	0.0112	0.0154	CcSEcCtD
Triamcinolone—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.011	0.0151	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.0106	0.0145	CcSEcCtD
Triamcinolone—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0145	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.0105	0.0145	CcSEcCtD
Triamcinolone—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0143	CcSEcCtD
Triamcinolone—NR3C1—nephron tubule—nephrolithiasis	0.0103	0.0377	CbGeAlD
Triamcinolone—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.0101	0.0139	CcSEcCtD
Triamcinolone—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.0098	0.0135	CcSEcCtD
Triamcinolone—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00966	0.0133	CcSEcCtD
Triamcinolone—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00956	0.0131	CcSEcCtD
Triamcinolone—NR3C1—renal system—nephrolithiasis	0.00934	0.0343	CbGeAlD
Triamcinolone—NR3C1—kidney—nephrolithiasis	0.00903	0.0331	CbGeAlD
Triamcinolone—NR3C1—cortex of kidney—nephrolithiasis	0.00879	0.0323	CbGeAlD
Triamcinolone—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0086	0.0118	CcSEcCtD
Triamcinolone—Erythema—Hydrochlorothiazide—nephrolithiasis	0.00838	0.0115	CcSEcCtD
Triamcinolone—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00821	0.0113	CcSEcCtD
Triamcinolone—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00811	0.0111	CcSEcCtD
Triamcinolone—PTGS2—renal system—nephrolithiasis	0.00808	0.0297	CbGeAlD
Triamcinolone—PTGS2—kidney—nephrolithiasis	0.00782	0.0287	CbGeAlD
Triamcinolone—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00778	0.0107	CcSEcCtD
Triamcinolone—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00766	0.0105	CcSEcCtD
Triamcinolone—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00756	0.0104	CcSEcCtD
Triamcinolone—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00753	0.0104	CcSEcCtD
Triamcinolone—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00752	0.0103	CcSEcCtD
Triamcinolone—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00737	0.0101	CcSEcCtD
Triamcinolone—Cough—Hydrochlorothiazide—nephrolithiasis	0.00732	0.0101	CcSEcCtD
Triamcinolone—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00714	0.00981	CcSEcCtD
Triamcinolone—CYP3A4—renal system—nephrolithiasis	0.00706	0.0259	CbGeAlD
Triamcinolone—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00705	0.00969	CcSEcCtD
Triamcinolone—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00698	0.0096	CcSEcCtD
Triamcinolone—Anaphylactic shock—Hydrochlorothiazide—nephrolithiasis	0.00684	0.00941	CcSEcCtD
Triamcinolone—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00684	0.00941	CcSEcCtD
Triamcinolone—CYP3A4—kidney—nephrolithiasis	0.00683	0.0251	CbGeAlD
Triamcinolone—Shock—Hydrochlorothiazide—nephrolithiasis	0.00673	0.00925	CcSEcCtD
Triamcinolone—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00668	0.00918	CcSEcCtD
Triamcinolone—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00661	0.00909	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00623	0.00857	CcSEcCtD
Triamcinolone—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00619	0.00851	CcSEcCtD
Triamcinolone—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00614	0.00845	CcSEcCtD
Triamcinolone—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.0061	0.00839	CcSEcCtD
Triamcinolone—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00602	0.00828	CcSEcCtD
Triamcinolone—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.0059	0.00811	CcSEcCtD
Triamcinolone—Pain—Hydrochlorothiazide—nephrolithiasis	0.00585	0.00804	CcSEcCtD
Triamcinolone—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00564	0.00775	CcSEcCtD
Triamcinolone—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.00544	0.00747	CcSEcCtD
Triamcinolone—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00541	0.00744	CcSEcCtD
Triamcinolone—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00504	0.00693	CcSEcCtD
Triamcinolone—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00491	0.00675	CcSEcCtD
Triamcinolone—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00484	0.00665	CcSEcCtD
Triamcinolone—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00452	0.00622	CcSEcCtD
Triamcinolone—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00435	0.00598	CcSEcCtD
Triamcinolone—Rash—Hydrochlorothiazide—nephrolithiasis	0.00431	0.00593	CcSEcCtD
Triamcinolone—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.00431	0.00592	CcSEcCtD
Triamcinolone—Headache—Hydrochlorothiazide—nephrolithiasis	0.00429	0.00589	CcSEcCtD
Triamcinolone—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00406	0.00559	CcSEcCtD
